Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Loma Al-Mansouri"'
Autor:
Mutlay Sayan, Astrid Langoe, Ozlem Aynaci, Ayfer Ay Eren, Mehmet Fuat Eren, Ilke Onur Kazaz, Zainab Ibrahim, Omar Tama Al-Akelie, Loma Al-Mansouri, Ramiz Abu-Hijlih, Shalini Moningi, Elia Abou Chawareb, Albert El Hajj, Peter F. Orio, Layth Mula-Hussain
Publikováno v:
BMC Urology, Vol 24, Iss 1, Pp 1-5 (2024)
Abstract Background Although prostate cancer is a prevalent malignancy worldwide, its clinical presentation and management in the Middle East are not well-documented. This study aims to provide insights into the initial clinical presentation and mana
Externí odkaz:
https://doaj.org/article/598e89a9f2df41c6acc69b4cb9f71ba8
Publikováno v:
The Iraqi Journal of Medical Sciences, Vol 17, Iss 3-4, Pp 168-174 (2019)
Background:The incidence of mortality and complications are high in patients with acute inferior wall ST-segment elevation myocardial infarction with right ventricular involvement, which has been reported to be an independent predictor of significant
Externí odkaz:
https://doaj.org/article/e7a7c69586d14bb4be431880cd97a327
Autor:
Loma Al-Mansouri, Firas AL-Obaidi, Rafid Bashir Altaweel, Enrique Soto-Perez-de-Celis, Hasan Al- Farhan, Noor A Abdullah, Laith Al-Rubaiy
Publikováno v:
Current Cancer Therapy Reviews. 19
Introduction:: Cancer is associated with a higher risk of venous thromboembolic events compared to the general population. About one-fifth of patients diagnosed with venous thromboembolic events have underlying cancer. The guidelines recommend both l
Autor:
Firas AL-Obaidi, Loma Al-Mansouri
Publikováno v:
Journal of Emergency Medicine, Trauma and Acute Care. 2022
Autor:
Howard Gurney, Loma Al-Mansouri
Publikováno v:
Asia-Pacific Journal of Clinical Oncology. 15:288-295
Prostate cancer is the most common malignancy in male patients. The second-generation taxanes, cabazitaxel, is a therapeutic option with an overall survival advantage for patients with metastatic castration-resistant prostate cancer. This review expl
Publikováno v:
Eur J Hosp Pharm
Aim Cabazitaxel prolongs survival in patients with metastatic castration-resistant prostate cancer in the postdocetaxel setting. We investigate the benefit of continuing cabazitaxel beyond 10 cycles in patients who are clinically responding without s
Autor:
Layth Mula, Hussain, Zineb, Benbrahim, Ghada M, Kunter, Zeinab, Elsayed, Nahla, Gafer, Alyaa Mula, Hussain, Loma, Al-Mansouri, Saif, Alizzi, Abdul-Rahman, Jazieh
Publikováno v:
The Gulf journal of oncology. 1(36)
Cancer is the leading cause of increased morbidity and mortality worldwide. This work aims to study the Arab-world females' cancers (AFCs), the similarities and disparities from epidemiological, economic and development-indices points of view.Descrip
Publikováno v:
Journal of Obstetrics and Gynaecology Research. 44:2190-2194
An elderly lady presented with a 2-year history of intermittent vaginal bleeding and later the development of a vulvovaginal mass. A core biopsy histology specimen from the mass and the left inguinal lymph node was suggestive of metastatic adenocarci
Autor:
Firas R. AL-Obaidi, Loma Al-Mansouri
Publikováno v:
Nowotwory. Journal of Oncology. 67:236-242
Pulmonary hypertension is a rare vascular disease that can affect patients with or surviving malignancy resulting in significant morbidity and high mortality. Malignant diseases can lead to elevated pulmonary artery pressure through different mechani
Autor:
Jenny Gilchrist, Elisabeth Elder, Farid Meybodi, James French, Nina Sriram, Alexander Brown, David Messer, Annelise Cocco, Richard F. Kefford, Loma Al-Mansouri, Jeremy Hsu
Publikováno v:
ANZ Journal of Surgery. 88:640-644
Background Neoadjuvant systemic therapy (NAST) can be used to treat breast cancer. Pathologic complete response (pCR) is a surrogate marker for improved survival. This study examined response in the breast and axilla to NAST and identified features a